insights_auto
Outlook: 35.5% bullish·16.1% bearish
Go to analysischevron_right
ARGX:NASDAQ
argenx SE - ADR
၈၁၂.၃၀ US$
arrow_downward
-၁.၅၄%(-၁၂.၇၃) 1D
၈၁၂.၃၀ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: အောက် ၁၂, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
၈၃၂.၃၃ US$
High
၈၃၂.၄၉ US$
Low
၈၁၀.၇၀ US$
Mkt. cap
ဋေ ၅.၀၆ ထ
Avg. vol.
၃.၄၀ သိန်း
Volume
၀.၀၀
P/E ratio
၃၀.၈၆
52-wk high
၁,၀၇၂.၇၅ US$
52-wk low
၆၆၁.၈၅ US$
EPS
၂၆.၃၂ US$
Beta
၀.၄၅
Shares outstanding
၆.၂၉ ကုဋေ
No. of employees
၂ ထောင်
Open
၈၃၂.၃၃ US$
High
၈၃၂.၄၉ US$
Low
၈၁၀.၇၀ US$
Mkt. cap
ဋေ ၅.၀၆ ထ
Avg. vol.
၃.၄၀ သိန်း
Volume
၀.၀၀
P/E ratio
၃၀.၈၆
52-wk high
၁,၀၇၂.၇၅ US$
52-wk low
၆၆၁.၈၅ US$
EPS
၂၆.၃၂ US$
Beta
၀.၄၅
Shares outstanding
၆.၂၉ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
The National Law Review
·
ပြီးခဲ့သည့် ၉ နာရီ
ARGX Investors with $100,000 in Losses Have Opportunity to Join argenx SE Fraud Investigation with SBS Law
GuruFocus
·
ပြီးခဲ့သည့် ၁၀ နာရီ
ARGX Maintains by Oppenheimer -- Price Target Lowered to $1038
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁၈ နာရီ
Argenx stock at EUR 745.20, 0.05 percent below its recent high
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၂၃ နာရီ
Argenx halts UNITY study. Argenx stock trades 1.18 percent higher
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR